AHF: Gilead’s $1,000 Hepatitis C Pill Target of SF, NYC Protests Feb.12th

  AHF: Gilead’s $1,000 Hepatitis C Pill Target of SF, NYC Protests Feb.12th

    Wednesday, Feb 12^th drug pricing protests target Gilead over price of
Sovaldi, its new Hepatitis C drug: $84,000 for a twelve week supply—or $1,000
                                  per pill!

  *New York City Protest—12pm to 1pm, Leerink Swann Global Healthcare
    Conference, Waldorf Astoria Hotel, 301 Park Ave, NY, NY 10022
  *San Francisco Protest March—12pm to 1pm, March from SF City Hall to the
    Federal Building

Business Wire

NEW YORK -- February 12, 2014

Advocates from AIDS Healthcare Foundation (AHF), the nation’s largest HIV/AIDS
nonprofit medical provider, is spearheading two protests in New York City and
San Francisco on Wednesday February 12th at 12 noon in each city targeting
Gilead Sciences over the price of Sovaldi (sofosbuvir), its new Hepatitis C
drug. The drug, which was approved by the Food and Drug Administration (FDA)
in early December, was immediately priced by Gilead at $84,000 Wholesale
Acquisition Cost (WAC) for a twelve-week supply of the drug—or $1,000 per
pill.

              
              
WHAT:             NEW YORK DRUG PRICING PROTEST/Gilead Sciences’ $1K Hepatitis
                  pill
                  
WHEN:             WEDNESDAY, Feb. 12,                     12:00 – 1:00pm
                  2014                                       EASTERN Time
                  
WHERE:            Leerink Swann Global Healthcare Conf., Waldorf Astoria
                  Hotel, 301 Park Ave, NYC 10022
                  
WHO:              Jessica Reinhart, Senior Grassroots Community Manager, AHF
                  Michael Camacho, MPH, NYC Regional Director, AHF
                  And 15-20 drug pricing advocates & protesters with
                  “Gilead-Outrage!” banners, signs and face masks
                  
NY CONTACT:    Jessica Reinhart, Senior Grassroots Community Manager, AHF
                  +1 (323) 203-6146.
                  
WHAT:             SAN FRANCISCO DRUG PRICING PROTEST MARCH/Gilead Sciences’
                  $1K pill
                  
WHEN:             WEDNESDAY, Feb. 12,                        12:00 – 1:00pm
                  2014                                       PACIFIC Time
                  
WHERE:            Marching FROM:
                  San Francisco CITY HALL, 1 Dr. Carlton B. Goodlett Place,
                  S.F., CA 94102
                  Marching TO:
                  San Francisco FEDERAL BUILDING, 90 7^th Street (corner
                  Mission & 7^th) S. F., CA 94103
                  
WHO:              Jesse Brooks, Regional Advocacy Consultant
                  Dale R. Gluth, Bay Area Regional Director, AHF
                  And 15-20 drug pricing advocates & protesters with
                  “Gilead-Outrage!” banners, signs and face masks
                  
SF CONTACT:    Jesse Brooks, Regional Advocacy Consultant (510) 575-8245.
                  

“Gilead’s $84,000 drug Sovaldi is only one portion of a two drug, twelve-week
combination treatment for Hepatitis C, which affects and estimated 3.2 million
people in the United States. The two-drug combo pushes treatment to well over
$100,000 per patient—a price point that is simply not sustainable,” said
Jessica Reinhart, Senior Grassroots  Community Manager, for AHF, in
anticipation of the New York protest held during the Leerink Swann Global
Healthcare Conference at the Waldorf Astoria Wednesday February 12^th.
“Gilead’s history of predatory pricing on its lifesaving medications—first on
its HIV drugs, and now, for this new hepatitis medication—sets the stage for
protests like ours as well as for direct action from government officials and
drug purchasers for government programs seeking to compel Gilead to cut its
outrageous pricing. We also want to let the financial industry know that we
are not going to simply stand by and watch this price gouging.”

“In addition to protesting the pricing of Sovaldi, our protests will serve as
a reminder of Gilead’s previous bad deeds in its pricing and policies,” said
Dale R. Gluth, Bay Area Regional Director for AHF in anticipation of the San
Francisco protest march from City Hall to the Federal Building set for
Wednesday February 12^th. “In late 2012, within days of FDA-approval of
Gilead’s four-in-one AIDS treatment combination Stribild, the company
immediately priced that treatment at $28,500 per patient, per year, Wholesale
Acquisition Cost (WAC)—a whopping 37% more than the price of Gilead’s
best-selling three-in-one AIDS treatment, Atripla. For the record, $28,500 is
more than most U.S. AIDS patients earn in any given year!”

“For Gilead, we have outrage, pure and simple,” said Michael Weinstein,
President of AIDS Healthcare Foundation. “There can be no better example of
the unbridled greed of the pharmaceutical industry than Gilead’s latest move:
pricing its new hepatitis drug at $28,000 per 28-tablet bottle or $1,000 per
pill! Gilead’s predatory pricing of Sovaldi is a direct threat to public
heath, and it sets the stage for legislators and advocates to demand that
officials who purchase drugs for government programs like Medicaid, Medicare
and the AIDS Drug Assistance Programs act decisively to rein in pricing and
protect patient access to lifesaving medications.”

Gilead did not even pay to research and develop Sovaldi. In 2011—for $11
billion in cash—it purchased Pharmasset, the company that had already
developed the drug. Advocates now believe the pricing of Sovaldi is being
driven by Gilead’s desire to recoup its financial investment in Pharmasset,
and assumes it can accomplish this by charging Medicaid and other
taxpayer-funded programs whatever it wants.

AIDS Healthcare Foundation (AHF), the largest global AIDS organization,
currently provides medical care and/or services to more than 282,000
individuals in 32 countries worldwide in the US, Africa, Latin
America/Caribbean, the Asia/Pacific Region and Eastern Europe. To learn more
about AHF, please visit our website: www.aidshealth.org, find us on Facebook:
www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare

Contact:

NEW YORK
AIDS Healthcare Foundation
Jessica Reinhart
Sr. Grassroots Community Mgr.
Cell: +1-323-203-6146
Jessica.reinhart@aidshealth.org
or
SAN FRANCISCO
AIDS Healthcare Foundation
Jesse Brooks
Regional Advocacy Consultant
Cell +1-510-575-8245
Jesse.brooks@aidshealth.org
pr
LOS ANGELES
AIDS Healthcare Foundation
Ged Kenslea
Senior Director, Communications
+1-323-308-1833 [work] +1-323-791-5526 [cell]
gedk@aidshealth.org
 
Press spacebar to pause and continue. Press esc to stop.